Evaluation of a parental training program for the management of childhood atopic dermatitis

Staab, Doris; Rueden, U. von; Kehrt, Rainer; Erhart, Michael; Wenninger, Kerstin; Kamtsiuris, Panagiotis; Wahn, Ulrich

doi:10.1034/j.1399-3038.2002.01005.x

Cited by 174 publications

(227 citation statements)

References 16 publications

Supporting

Mentioning

205

Contrasting

Unclassified

Order By: Relevance

“…Six new studies reported since 2000 [350][351][352][353][354][355] have looked at eczema education sessions for children, parents and carers, with all using slightly different approaches. Overall, the interventions in this section are quite diverse with regard to the components and intensity of the interventions, with time spent on the education ranging from 15 minutes to 2 weeks.…”

Section: (See Appendix 3)mentioning

confidence: 99%

“…A study by Staab and colleagues 352 in 2002 looked at a parental training programme. Ninety-three participants received 2-hour training sessions (once a week for 6 weeks) and 111 participants did not receive any training.…”

Section: (See Appendix 3)mentioning

confidence: 99%

“…Four 351,352,354,355 of the six trials reported significant beneficial effects of the educational interventions on the severity of eczema. The larger study by Staab and colleagues 351 reported significant between-group differences for reduction in eczema severity, measured using the SCORAD index, for all three age groups.…”

Section: Clinically Assessed Severitymentioning

confidence: 99%

See 2 more Smart Citations

Scoping systematic review of treatments for eczema

Nankervis

Kim

Delamere

et al. 2016

Programme Grants Appl Res

View full text Add to dashboard Cite

BackgroundEczema is a very common chronic inflammatory skin condition.ObjectivesTo update the National Institute for Health Research (NIHR) Health Technology Assessment (HTA) systematic review of treatments for atopic eczema, published in 2000, and to inform health-care professionals, commissioners and patients about key treatment developments and research gaps.Data sourcesElectronic databases including MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, Cochrane Skin Group Specialised Register, Latin American and Caribbean Health Sciences Literature (LILACS), Allied and Complementary Medicine Database (AMED) and Cumulative Index to Nursing and Allied Health Literature (CINAHL) were searched from the end of 2000 to 31 August 2013. Retrieved articles were used to identify further randomised controlled trials (RCTs).Review methodsStudies were filtered according to inclusion criteria and agreed by consensus in cases of uncertainty. Abstracts were excluded and non-English-language papers were screened by international colleagues and data were extracted. Only RCTs of treatments for eczema were included, as other forms of evidence are associated with higher risks of bias. Inclusion criteria for studies included availability of data relevant to the therapeutic management of eczema; mention of randomisation; comparison of two or more treatments; and prospective data collection. Participants of all ages were included. Eczema diagnosis was determined by a clinician or according to published diagnostic criteria. The risk of bias was assessed using the Cochrane Collaboration risk-of-bias tool. We used a standardised approach to summarising the data and the assessment of risk of bias and we made a clear distinction between what the studies found and our own interpretation of study findings.ResultsOf 7198 references screened, 287 new trials were identified spanning 92 treatments. Trial reporting was generally poor (randomisation method: 2% high, 36% low, 62% unclear risk of bias; allocation concealment: 3% high, 15% low, 82% unclear risk of bias; blinding of the intervention: 15% high, 28% low, 57% unclear risk of bias). Only 22 (8%) trials were considered to be at low risk of bias for all three criteria. There was reasonable evidence of benefit for the topical medications tacrolimus, pimecrolimus and various corticosteroids (with tacrolimus superior to pimecrolimus and corticosteroids) for both treatment and flare prevention; oral ciclosporin; oral azathioprine; narrow band ultraviolet B (UVB) light; Atopiclair™ and education. There was reasonable evidence to suggest no clinically useful benefit for twice-daily compared with once-daily topical corticosteroids; corticosteroids containing antibiotics for non-infected eczema; probiotics; evening primrose and borage oil; ion-exchange water softeners; protease inhibitor SRD441 (Serentis Ltd); furfuryl palmitate in emollient; cipamfylline cream; andMycobacterium vaccaevaccine. Additional research evidence is needed for emollients, bath additives, antibacterials, specialist clothing and complementary and alternative therapies. There was no RCT evidence for topical corticosteroid dilution, impregnated bandages, soap avoidance, bathing frequency or allergy testing.LimitationsThe large scope of the review coupled with the heterogeneity of outcomes precluded formal meta-analyses. Our conclusions are still limited by a profusion of small, poorly reported studies.ConclusionsAlthough the evidence base of RCTs has increased considerably since the last NIHR HTA systematic review, the field is still severely hampered by poor design and reporting problems including failure to register trials and declare primary outcomes, small sample size, short follow-up duration and poor reporting of risk of bias. Key areas for further research identified by the review include the optimum use of emollients, bathing frequency, wash products, allergy testing and antiseptic treatments. Perhaps the greatest benefit identified is the use of twice weekly anti-inflammatory treatment to maintain disease remission. More studies need to be conducted in a primary care setting where most people with eczema are seen in the UK. Future studies need to use the same core set of outcomes that capture patient symptoms, clinical signs, quality of life and the chronic nature of the disease.FundingThe National Institute for Health Research Programme Grants for Applied Research programme.

show abstract

Section: (See Appendix 3)mentioning

confidence: 99%

Section: (See Appendix 3)mentioning

confidence: 99%

See 1 more Smart Citation

Scoping systematic review of treatments for eczema

Nankervis

Kim

Delamere

et al. 2016

Programme Grants Appl Res

View full text Add to dashboard Cite

show abstract

“…Its early onset in infancy and chronic relapsing course puts special burden on their families 1 . Children with AD often have behavioral problems such as increased dependency, fearfulness and sleep difficulties 2 .…”

Section: Introductionmentioning

confidence: 99%

“…Children with AD often have behavioral problems such as increased dependency, fearfulness and sleep difficulties 2 . Supporting parents in dealing with the management of AD presents a challenge for physicians 1 . Educational programs for parents and patients with AD have been established in the last ten years in different European countries [3][4][5][6] .…”

Section: Introductionmentioning

confidence: 99%

Importance of Educational Intervention and Parental Knowledge on Atopic Dermatitis in Children

Kotrulja¹

2016

ACC

View full text Add to dashboard Cite

SUMMARY -Atopic dermatitis (AD) is a chronic relapsing, inflammatory skin disease. Failure to treat AD successfully can often be directly linked to poor treatment adherence as a result of the lack of information about the disease and basic principles of treatment. Several studies have found that making patients active participants in their care through information and education is a successful treatment strategy in AD. The aim of this study was to evaluate parental knowledge on AD and to stress the importance of therapeutic educational program in long term management and control of the disease. We carried out a short questionnaire-based study among 238 parents of children with AD regarding their knowledge on the etiology and treatment of AD. Our results showed that 21% of the participants reported corticophobia and were concerned about systemic absorption affecting the child's growth and development even after short application. In children with AD who have food hypersensitivity, 14% of parents thought that a small amount of food allergen could be beneficial in achieving tolerability. The role of interdisciplinary educational program is to explain the epidemiology and pathogenesis of AD, as well as concomitant atopy related diseases and to teach parents about the importance of appropriate skin care.

show abstract

Psychological and educational interventions for atopic eczema in children

Ersser¹,

Latter²,

Sibley³

et al. 2007

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

A lack of rigorously designed trials (excluding one recent German study) provides only limited evidence of the effectiveness of educational and psychological interventions in helping to manage the condition of children with atopic eczema. Evidence from included studies and also adult studies indicates that different service delivery models (multi-professional eczema school and nurse-led clinics) require further and comparative evaluation to examine their cost-effectiveness and suitability for different health systems.

show abstract

Evaluation of a parental training program for the management of childhood atopic dermatitis

Cited by 174 publications

References 16 publications

Scoping systematic review of treatments for eczema

Scoping systematic review of treatments for eczema

Importance of Educational Intervention and Parental Knowledge on Atopic Dermatitis in Children

Psychological and educational interventions for atopic eczema in children

Contact Info

Product

Resources

About